Home Tags Rege Nephro

Rege Nephro

Regenephro Inc. (Headquarters: Kyoto City, CEO: Shofumi Morinaka) has recently completed a Series B round of funding, raising funds through third-party allotments to DCI Partners Inc., JIC Venture Growth Investments Inc., Nippon Venture Capital Co., Ltd., Tohoku University Venture Partners Inc., Golden Asia Fund Ventures Ltd., Mitsui Chemicals Inc., Global Brain Inc., Kyoto University Innovation Capital Co., Ltd., JAFCO Group Co., Ltd., Mitsubishi UFJ Capital Co., Ltd., QB2 Partners Limited Liability Partnership, Asahi Kasei Corporation, and others (as listed in the attached table).

Rege Nephro Co. Secures Series B Funding

Team SR -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version